机器学习利用常规临床数据预测肝细胞癌风险:大型多中心人群研究
研究基于UK Biobank(开发)和All of Us(外部测试)两个人群队列,利用超90万个体、983例肝细胞癌(HCC)的多模态数据,构建可解释的机器学习框架PRE-Screen-HCC。最终随机森林模型在内部和外部测试集中均显著优于所有公开的最先进风险评分,并在不同种族亚组中表现稳健。
要点
- 基于常规临床数据训练的ML模型预测HCC风险优于现有公开评分。
- 模型性能与代谢组学和基因组学数据相当,且具有可解释性。
- 研究公开了代码、模型权重和网络计算器供外部验证与智能体整合。
核心结论
- PRE-Screen-HCC是一个稳健且可解释的机器学习框架,可用于HCC风险分层和早期检测。
研究设计与样本
- 研究利用UK Biobank(开发队列)和All of Us研究项目(外部测试队列)两个人群规模队列的前瞻性多模态数据。
- 共纳入超过900,000个体和983例HCC病例,评估了人口统计学、生活方式、健康记录、血液、基因组学和代谢组学等多模态数据的个体和累积贡献。
主要发现
- 最终基于随机森林的模型在内部和外部测试集中均显著优于所有公开可用的最先进风险评分。
- 模型在不同种族亚组中表现稳健,并提供了全面的可解释性。
临床怎么用
- 该框架可基于常规收集的临床数据进行HCC风险分层,辅助早期检测。
- 研究发布了所有代码、模型权重和网络计算器,便于外部验证和智能体整合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hepatocellular carcinoma (HCC) is a highly fatal tumor, for which risk stratification is crucial yet remains challenging. In this study, we develop an interpretable machine learning (ML) framework for HCC risk stratification based on routinely collected clinical data. We utilize prospectively collected multimodal data from more than 900,000 individuals and 983 cases of HCC across two population-scale cohorts: the UK Biobank study (development) and the All of Us Research Program (external testing). We assess individual and cumulative contributions of data modalities, including demographics, lifestyle, health records, blood, genomics, and metabolomics. Our final random forest-based models significantly outperform all publicly available state-of-the-art risk scores on both internal and external test sets. We demonstrate robustness across ethnic subgroups, provide comprehensive interpretability, and release all code, model weights, and a web calculator for external validation and agentic integration. Our study presents PRE-Screen-HCC, a robust and interpretable ML framework for HCC risk stratification and early detection. SIGNIFICANCE: Using data from population-scale cohorts, we develop and externally validate an ML framework for HCC risk stratification. Models trained on routine clinical data outperform published scores, perform on par with metabolomics and genomics, generalize across subgroups, and remain interpretable. See related commentary by Foda, p. 1252.
引用
- Clusmann J, Koop PH, Zhang DY, et al. Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study. Cancer Discov. 2026. PMID: 41881847. doi:10.1158/2159-8290.CD-25-1323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。